Articles
	12/19/2008	M&As Are Blazing Hot The financial crisis of 2008 has wreaked havoc in virtually every sector of the economy – including once-safe havens like biotech and big pharma. But adverse conditions have created an unprecedented opportunity for buyouts, and biotech M&As are hotter than ever.
	8/28/2008	Is Bigger Really Better? Biotech and big pharma firms have inked 25 $1 billion-plus alliances since 2001, most of them in the last year or two. Are the sky-high prices mostly window dressing, or do they indicate a profound shift in partnering strategy?
	6/27/2008	20 Compounds That Defined Biotech In celebration of Recombinant Capital’s 20th year, we are recounting the storied history of 20 biologics that helped to define biotechnology – and continue to do so.
	4/02/2008	Much Ado About Biologics Most big pharmas have been slowly building their stores of protein- and antibody-based medicines, but they picked up the pace in 2007 with a series of clever acquisitions.
	2/29/2008	FDA Deals Biotech A Winning Hand While it’s true that product approvals lagged last year, the FDA still gave the nod to a number of important new drugs, biologics and vaccines – including two new classes of AIDS drugs and three more targeted cancer therapies. Nearly half of them have biotech origins.
	1/06/2008	Another Stellar Year Despite a year-end slump, biotech and specialty pharma firms raised a whopping $26.5 billion in 2007 – mirroring the sector’s haul in 2006 and setting a new standard. It was a brilliant performance, but once again a handful of biotech’s brightest stars carried the show.
top
		Buzz
	10/01/2008	Drug Safety Watchdog Increases Vigilance
	5/28/2008	Biotechs & Big Pharmas Feel The Pain
	3/14/2008	Starter Drugs: Aggrastat
	1/15/2008	IPO Tracker
top
		Focal Point
	10/24/2008	Déjà vu All Over Again
	7/24/2008	Financing Slows to A Trickle
	4/29/2008	Allicense 2008: The Cream Of The Crop
	2/05/2008	Global Health Initiatives Gain Traction
top
		School Zone
	1/23/2008	Tech Transfer: Harnessing Innovation
top
		Signals vs Noise
	10/17/2008	Financial Snapshot For September 2008: The Sky Is Falling
	4/16/2008	Financial Snapshot For March 2008: Batten Down The Hatches
	1/17/2008	Financial Snapshot For December 2007: A Cautionary Tale
top
		Signals vs Noise
	7/09/2008	Financial Snapshot For June 2008: Dire Straits
top
		Turn Signals
	11/14/2008	Royalty Rates Revealed
	9/23/2008	Flu Season Nears: Be Prepared
	5/01/2008	Blockbusters Just Keep On Coming
	3/05/2008	Approval Times Stay On Track
top
		Trivia
	12/31/2008	Microbia
	12/24/2008	Ice Structuring Proteins
	12/17/2008	Episomes
	12/10/2008	Aflatoxins
	12/03/2008	Plasmodesmata
	11/26/2008	Personalized Medicine
	11/19/2008	Field Trial
	11/12/2008	Space Research
	11/05/2008	Blood
	10/29/2008	UBE
	10/22/2008	Annexins
	10/15/2008	Spidroin
	10/08/2008	Oncothyreon
	10/01/2008	Gulo
	9/23/2008	Chromosome
	9/17/2008	Janssen Award
	9/10/2008	Asthma
	9/03/2008	SIB
	8/27/2008	Toxic
	8/20/2008	Marfan syndrome
	8/13/2008	Posilac
	8/06/2008	Virusoid
	7/30/2008	Illumina
	7/23/2008	B12
	7/16/2008	Sirigen
	7/09/2008	Ulcers
	7/02/2008	Crystals
	6/25/2008	Dog Days
	6/11/2008	Calmodulin
	6/04/2008	Weird Animals
	5/28/2008	StemCo
	5/21/2008	Deal of the Year
	5/07/2008	Human Chromosome
	4/30/2008	Kinases
	4/23/2008	Screening
	4/16/2008	Mycometrix
	4/09/2008	HGH Recap
	4/02/2008	Big Dogs
	3/26/2008	Spin-Out
	3/19/2008	Zinc Fingers
	3/12/2008	Origins
	3/05/2008	AZT
	2/27/2008	Ubiquitin
	2/20/2008	Xtal
	2/13/2008	Tubulin
	2/06/2008	Aequorin
	1/30/2008	NAS Award
	1/23/2008	Bence-Jones
	1/16/2008	Name Game
	1/09/2008	Balancing Act
	1/02/2008	DNA Virus
top